Laboratorios Rovi : Appealing upside and net cash to make the wait for the catalyst bearable
>Fully integrated and well diversified specialty pharma - Rovi is a fully integrated and well diversified specialty pharma. The company is focused on prescription drugs (54% of sales), both in-house and license. Additionally, it has a CMO business (41% of sales) which has recently trebled in size thanks to an agreement with Moderna. Finally, it also has a contrast agents’ unit and a residual OTC business. In recent years the company has consolidated its franchise as a...Laboratorios Farmaceuticos Rovi is engaged in the sale of its own pharmaceutical products and the distribution of other products for which it holds licenses granted by other laboratories for specific periods, in accordance with the terms and conditions contained in the agreements entered into with said laboratories.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.